首页> 外文OA文献 >Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial.

【2h】

Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial.

机译：新的S（-）-氨氯地平烟酸酯与消旋苯磺酸氨氯地平对成人成年轻度至中度高血压患者的疗效和安全性：8周，多中心，随机，双盲，双假，平行组，第三阶段，非劣效性临床试验。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kim SA; Park S; Chung N; Lim DS; Yang JY; Oh BH; Tahk SJ; Ahn TH;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献

1. Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, Parallel-Group, Phase III, Noninferiority Clinical Trial [J] . Kim SA, Park S, Chung N, Clinical therapeutics . 2008,第5期

机译：新型S（-）-烟酸氨氯地平与消旋苯磺酸氨氯地平对成人成年轻度至中度高血压患者的疗效和安全性：8周，多中心，随机，双盲，双假，平行组，非劣效性临床试验第三阶段
2. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hype [J] . Park S, Chung N, Kwon J, Clinical therapeutics . 2005,第4期

机译：一项多中心，8周，平行分组，随机，双盲，双模拟的III期临床试验的结果，用于评估马来酸氨氯地平与苯磺酸氨氯地平对轻度至中度炒作的疗效和耐受性
3. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension. [J] . Kim SH, Kim YD, Lim DS, Clinical therapeutics . 2007,第9期

机译：一项III期，为期8周，多中心，前瞻性，随机，双盲，平行组的临床试验的结果，用于评估氨氯地平与苯磺酸氨氯地平对韩国轻度至中度高血压患者的影响。
4. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week multicenter randomized double-blind Phase III clinical study [O] . Sang-Hyun Ihm, Hui-Kyung Jeon, Tae-Joon Cha, 2016

机译：S-氨氯地平和替米沙坦的两种固定剂量组合（CKD-828）与S-氨氯地平单药治疗在S-氨氯地平单药治疗不能充分控制的高血压患者中的疗效和安全性：8周多中心随机双盲 III期临床研究
5. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial. [O] . Hong SJ, Ahn TH, Baek SH, 2011

机译：成人轻度至中度高血压患者乳清酸氨氯地平与苯磺酸氨氯地平的疗效和耐受性比较：一项多中心，随机，双盲，安慰剂对照，平行组，8周随访，非劣效性试验。

Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial.

著录项

引文网络

相似文献

相关主题

期刊订阅